Medical Care
Global AI In Oncology Market Research Report 2025
- Mar 11, 25
- ID: 76231
- Pages: 72
- Figures: 77
- Views: 20
The global market for AI In Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The application of AI in cancer practice includes providing clinical decision support for cancer diagnosis and screening, processing medical data for cancer detection or characterization of patient prognosis, and optimizing care delivery and clinical operations by increasing system capacity and allocating resources.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.131%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for AI In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Oncology.
The AI In Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI In Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI In Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Azra AI
IBM
Siemens Healthineers
Intel
GE Healthcare
NVIDIA
Digital Diagnostics Inc.
Concert.AI
Median Technologies
Path AI
Segment by Type
Software Solutions
Hardware
Services
Segment by Application
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI In Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The application of AI in cancer practice includes providing clinical decision support for cancer diagnosis and screening, processing medical data for cancer detection or characterization of patient prognosis, and optimizing care delivery and clinical operations by increasing system capacity and allocating resources.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.131%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for AI In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Oncology.
The AI In Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI In Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI In Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Azra AI
IBM
Siemens Healthineers
Intel
GE Healthcare
NVIDIA
Digital Diagnostics Inc.
Concert.AI
Median Technologies
Path AI
Segment by Type
Software Solutions
Hardware
Services
Segment by Application
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI In Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI In Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software Solutions
1.2.3 Hardware
1.2.4 Services
1.3 Market by Application
1.3.1 Global AI In Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Prostate Cancer
1.3.5 Colorectal Cancer
1.3.6 Brain Tumor
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI In Oncology Market Perspective (2020-2031)
2.2 Global AI In Oncology Growth Trends by Region
2.2.1 Global AI In Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI In Oncology Historic Market Size by Region (2020-2025)
2.2.3 AI In Oncology Forecasted Market Size by Region (2026-2031)
2.3 AI In Oncology Market Dynamics
2.3.1 AI In Oncology Industry Trends
2.3.2 AI In Oncology Market Drivers
2.3.3 AI In Oncology Market Challenges
2.3.4 AI In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI In Oncology Players by Revenue
3.1.1 Global Top AI In Oncology Players by Revenue (2020-2025)
3.1.2 Global AI In Oncology Revenue Market Share by Players (2020-2025)
3.2 Global AI In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI In Oncology Revenue
3.4 Global AI In Oncology Market Concentration Ratio
3.4.1 Global AI In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI In Oncology Revenue in 2024
3.5 Global Key Players of AI In Oncology Head office and Area Served
3.6 Global Key Players of AI In Oncology, Product and Application
3.7 Global Key Players of AI In Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI In Oncology Breakdown Data by Type
4.1 Global AI In Oncology Historic Market Size by Type (2020-2025)
4.2 Global AI In Oncology Forecasted Market Size by Type (2026-2031)
5 AI In Oncology Breakdown Data by Application
5.1 Global AI In Oncology Historic Market Size by Application (2020-2025)
5.2 Global AI In Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI In Oncology Market Size (2020-2031)
6.2 North America AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI In Oncology Market Size by Country (2020-2025)
6.4 North America AI In Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI In Oncology Market Size (2020-2031)
7.2 Europe AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI In Oncology Market Size by Country (2020-2025)
7.4 Europe AI In Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI In Oncology Market Size (2020-2031)
8.2 Asia-Pacific AI In Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI In Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific AI In Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI In Oncology Market Size (2020-2031)
9.2 Latin America AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI In Oncology Market Size by Country (2020-2025)
9.4 Latin America AI In Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI In Oncology Market Size (2020-2031)
10.2 Middle East & Africa AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI In Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa AI In Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Azra AI
11.1.1 Azra AI Company Details
11.1.2 Azra AI Business Overview
11.1.3 Azra AI AI In Oncology Introduction
11.1.4 Azra AI Revenue in AI In Oncology Business (2020-2025)
11.1.5 Azra AI Recent Development
11.2 IBM
11.2.1 IBM Company Details
11.2.2 IBM Business Overview
11.2.3 IBM AI In Oncology Introduction
11.2.4 IBM Revenue in AI In Oncology Business (2020-2025)
11.2.5 IBM Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers AI In Oncology Introduction
11.3.4 Siemens Healthineers Revenue in AI In Oncology Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel AI In Oncology Introduction
11.4.4 Intel Revenue in AI In Oncology Business (2020-2025)
11.4.5 Intel Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare AI In Oncology Introduction
11.5.4 GE Healthcare Revenue in AI In Oncology Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 NVIDIA
11.6.1 NVIDIA Company Details
11.6.2 NVIDIA Business Overview
11.6.3 NVIDIA AI In Oncology Introduction
11.6.4 NVIDIA Revenue in AI In Oncology Business (2020-2025)
11.6.5 NVIDIA Recent Development
11.7 Digital Diagnostics Inc.
11.7.1 Digital Diagnostics Inc. Company Details
11.7.2 Digital Diagnostics Inc. Business Overview
11.7.3 Digital Diagnostics Inc. AI In Oncology Introduction
11.7.4 Digital Diagnostics Inc. Revenue in AI In Oncology Business (2020-2025)
11.7.5 Digital Diagnostics Inc. Recent Development
11.8 Concert.AI
11.8.1 Concert.AI Company Details
11.8.2 Concert.AI Business Overview
11.8.3 Concert.AI AI In Oncology Introduction
11.8.4 Concert.AI Revenue in AI In Oncology Business (2020-2025)
11.8.5 Concert.AI Recent Development
11.9 Median Technologies
11.9.1 Median Technologies Company Details
11.9.2 Median Technologies Business Overview
11.9.3 Median Technologies AI In Oncology Introduction
11.9.4 Median Technologies Revenue in AI In Oncology Business (2020-2025)
11.9.5 Median Technologies Recent Development
11.10 Path AI
11.10.1 Path AI Company Details
11.10.2 Path AI Business Overview
11.10.3 Path AI AI In Oncology Introduction
11.10.4 Path AI Revenue in AI In Oncology Business (2020-2025)
11.10.5 Path AI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI In Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Software Solutions
1.2.3 Hardware
1.2.4 Services
1.3 Market by Application
1.3.1 Global AI In Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Prostate Cancer
1.3.5 Colorectal Cancer
1.3.6 Brain Tumor
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI In Oncology Market Perspective (2020-2031)
2.2 Global AI In Oncology Growth Trends by Region
2.2.1 Global AI In Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI In Oncology Historic Market Size by Region (2020-2025)
2.2.3 AI In Oncology Forecasted Market Size by Region (2026-2031)
2.3 AI In Oncology Market Dynamics
2.3.1 AI In Oncology Industry Trends
2.3.2 AI In Oncology Market Drivers
2.3.3 AI In Oncology Market Challenges
2.3.4 AI In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI In Oncology Players by Revenue
3.1.1 Global Top AI In Oncology Players by Revenue (2020-2025)
3.1.2 Global AI In Oncology Revenue Market Share by Players (2020-2025)
3.2 Global AI In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI In Oncology Revenue
3.4 Global AI In Oncology Market Concentration Ratio
3.4.1 Global AI In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI In Oncology Revenue in 2024
3.5 Global Key Players of AI In Oncology Head office and Area Served
3.6 Global Key Players of AI In Oncology, Product and Application
3.7 Global Key Players of AI In Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI In Oncology Breakdown Data by Type
4.1 Global AI In Oncology Historic Market Size by Type (2020-2025)
4.2 Global AI In Oncology Forecasted Market Size by Type (2026-2031)
5 AI In Oncology Breakdown Data by Application
5.1 Global AI In Oncology Historic Market Size by Application (2020-2025)
5.2 Global AI In Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI In Oncology Market Size (2020-2031)
6.2 North America AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI In Oncology Market Size by Country (2020-2025)
6.4 North America AI In Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI In Oncology Market Size (2020-2031)
7.2 Europe AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI In Oncology Market Size by Country (2020-2025)
7.4 Europe AI In Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI In Oncology Market Size (2020-2031)
8.2 Asia-Pacific AI In Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI In Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific AI In Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI In Oncology Market Size (2020-2031)
9.2 Latin America AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI In Oncology Market Size by Country (2020-2025)
9.4 Latin America AI In Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI In Oncology Market Size (2020-2031)
10.2 Middle East & Africa AI In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI In Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa AI In Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Azra AI
11.1.1 Azra AI Company Details
11.1.2 Azra AI Business Overview
11.1.3 Azra AI AI In Oncology Introduction
11.1.4 Azra AI Revenue in AI In Oncology Business (2020-2025)
11.1.5 Azra AI Recent Development
11.2 IBM
11.2.1 IBM Company Details
11.2.2 IBM Business Overview
11.2.3 IBM AI In Oncology Introduction
11.2.4 IBM Revenue in AI In Oncology Business (2020-2025)
11.2.5 IBM Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers AI In Oncology Introduction
11.3.4 Siemens Healthineers Revenue in AI In Oncology Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel AI In Oncology Introduction
11.4.4 Intel Revenue in AI In Oncology Business (2020-2025)
11.4.5 Intel Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare AI In Oncology Introduction
11.5.4 GE Healthcare Revenue in AI In Oncology Business (2020-2025)
11.5.5 GE Healthcare Recent Development
11.6 NVIDIA
11.6.1 NVIDIA Company Details
11.6.2 NVIDIA Business Overview
11.6.3 NVIDIA AI In Oncology Introduction
11.6.4 NVIDIA Revenue in AI In Oncology Business (2020-2025)
11.6.5 NVIDIA Recent Development
11.7 Digital Diagnostics Inc.
11.7.1 Digital Diagnostics Inc. Company Details
11.7.2 Digital Diagnostics Inc. Business Overview
11.7.3 Digital Diagnostics Inc. AI In Oncology Introduction
11.7.4 Digital Diagnostics Inc. Revenue in AI In Oncology Business (2020-2025)
11.7.5 Digital Diagnostics Inc. Recent Development
11.8 Concert.AI
11.8.1 Concert.AI Company Details
11.8.2 Concert.AI Business Overview
11.8.3 Concert.AI AI In Oncology Introduction
11.8.4 Concert.AI Revenue in AI In Oncology Business (2020-2025)
11.8.5 Concert.AI Recent Development
11.9 Median Technologies
11.9.1 Median Technologies Company Details
11.9.2 Median Technologies Business Overview
11.9.3 Median Technologies AI In Oncology Introduction
11.9.4 Median Technologies Revenue in AI In Oncology Business (2020-2025)
11.9.5 Median Technologies Recent Development
11.10 Path AI
11.10.1 Path AI Company Details
11.10.2 Path AI Business Overview
11.10.3 Path AI AI In Oncology Introduction
11.10.4 Path AI Revenue in AI In Oncology Business (2020-2025)
11.10.5 Path AI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI In Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software Solutions
Table 3. Key Players of Hardware
Table 4. Key Players of Services
Table 5. Global AI In Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global AI In Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global AI In Oncology Market Share by Region (2020-2025)
Table 9. Global AI In Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global AI In Oncology Market Share by Region (2026-2031)
Table 11. AI In Oncology Market Trends
Table 12. AI In Oncology Market Drivers
Table 13. AI In Oncology Market Challenges
Table 14. AI In Oncology Market Restraints
Table 15. Global AI In Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global AI In Oncology Market Share by Players (2020-2025)
Table 17. Global Top AI In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Oncology as of 2024)
Table 18. Ranking of Global Top AI In Oncology Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by AI In Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of AI In Oncology, Headquarters and Area Served
Table 21. Global Key Players of AI In Oncology, Product and Application
Table 22. Global Key Players of AI In Oncology, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI In Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global AI In Oncology Revenue Market Share by Type (2020-2025)
Table 26. Global AI In Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global AI In Oncology Revenue Market Share by Type (2026-2031)
Table 28. Global AI In Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global AI In Oncology Revenue Market Share by Application (2020-2025)
Table 30. Global AI In Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global AI In Oncology Revenue Market Share by Application (2026-2031)
Table 32. North America AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific AI In Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific AI In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific AI In Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 47. Azra AI Company Details
Table 48. Azra AI Business Overview
Table 49. Azra AI AI In Oncology Product
Table 50. Azra AI Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 51. Azra AI Recent Development
Table 52. IBM Company Details
Table 53. IBM Business Overview
Table 54. IBM AI In Oncology Product
Table 55. IBM Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 56. IBM Recent Development
Table 57. Siemens Healthineers Company Details
Table 58. Siemens Healthineers Business Overview
Table 59. Siemens Healthineers AI In Oncology Product
Table 60. Siemens Healthineers Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 61. Siemens Healthineers Recent Development
Table 62. Intel Company Details
Table 63. Intel Business Overview
Table 64. Intel AI In Oncology Product
Table 65. Intel Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 66. Intel Recent Development
Table 67. GE Healthcare Company Details
Table 68. GE Healthcare Business Overview
Table 69. GE Healthcare AI In Oncology Product
Table 70. GE Healthcare Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 71. GE Healthcare Recent Development
Table 72. NVIDIA Company Details
Table 73. NVIDIA Business Overview
Table 74. NVIDIA AI In Oncology Product
Table 75. NVIDIA Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 76. NVIDIA Recent Development
Table 77. Digital Diagnostics Inc. Company Details
Table 78. Digital Diagnostics Inc. Business Overview
Table 79. Digital Diagnostics Inc. AI In Oncology Product
Table 80. Digital Diagnostics Inc. Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 81. Digital Diagnostics Inc. Recent Development
Table 82. Concert.AI Company Details
Table 83. Concert.AI Business Overview
Table 84. Concert.AI AI In Oncology Product
Table 85. Concert.AI Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 86. Concert.AI Recent Development
Table 87. Median Technologies Company Details
Table 88. Median Technologies Business Overview
Table 89. Median Technologies AI In Oncology Product
Table 90. Median Technologies Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 91. Median Technologies Recent Development
Table 92. Path AI Company Details
Table 93. Path AI Business Overview
Table 94. Path AI AI In Oncology Product
Table 95. Path AI Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 96. Path AI Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. AI In Oncology Picture
Figure 2. Global AI In Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI In Oncology Market Share by Type: 2024 VS 2031
Figure 4. Software Solutions Features
Figure 5. Hardware Features
Figure 6. Services Features
Figure 7. Global AI In Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global AI In Oncology Market Share by Application: 2024 VS 2031
Figure 9. Breast Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Colorectal Cancer Case Studies
Figure 13. Brain Tumor Case Studies
Figure 14. Others Case Studies
Figure 15. AI In Oncology Report Years Considered
Figure 16. Global AI In Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global AI In Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global AI In Oncology Market Share by Region: 2024 VS 2031
Figure 19. Global AI In Oncology Market Share by Players in 2024
Figure 20. Global Top AI In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Oncology as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by AI In Oncology Revenue in 2024
Figure 22. North America AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America AI In Oncology Market Share by Country (2020-2031)
Figure 24. United States AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe AI In Oncology Market Share by Country (2020-2031)
Figure 28. Germany AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific AI In Oncology Market Share by Region (2020-2031)
Figure 36. China AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America AI In Oncology Market Share by Country (2020-2031)
Figure 44. Mexico AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa AI In Oncology Market Share by Country (2020-2031)
Figure 48. Turkey AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Azra AI Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 52. IBM Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 53. Siemens Healthineers Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 54. Intel Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 56. NVIDIA Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 57. Digital Diagnostics Inc. Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 58. Concert.AI Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 59. Median Technologies Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 60. Path AI Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global AI In Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Software Solutions
Table 3. Key Players of Hardware
Table 4. Key Players of Services
Table 5. Global AI In Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global AI In Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global AI In Oncology Market Share by Region (2020-2025)
Table 9. Global AI In Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global AI In Oncology Market Share by Region (2026-2031)
Table 11. AI In Oncology Market Trends
Table 12. AI In Oncology Market Drivers
Table 13. AI In Oncology Market Challenges
Table 14. AI In Oncology Market Restraints
Table 15. Global AI In Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global AI In Oncology Market Share by Players (2020-2025)
Table 17. Global Top AI In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Oncology as of 2024)
Table 18. Ranking of Global Top AI In Oncology Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by AI In Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of AI In Oncology, Headquarters and Area Served
Table 21. Global Key Players of AI In Oncology, Product and Application
Table 22. Global Key Players of AI In Oncology, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI In Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global AI In Oncology Revenue Market Share by Type (2020-2025)
Table 26. Global AI In Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global AI In Oncology Revenue Market Share by Type (2026-2031)
Table 28. Global AI In Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global AI In Oncology Revenue Market Share by Application (2020-2025)
Table 30. Global AI In Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global AI In Oncology Revenue Market Share by Application (2026-2031)
Table 32. North America AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific AI In Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific AI In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific AI In Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa AI In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa AI In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa AI In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 47. Azra AI Company Details
Table 48. Azra AI Business Overview
Table 49. Azra AI AI In Oncology Product
Table 50. Azra AI Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 51. Azra AI Recent Development
Table 52. IBM Company Details
Table 53. IBM Business Overview
Table 54. IBM AI In Oncology Product
Table 55. IBM Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 56. IBM Recent Development
Table 57. Siemens Healthineers Company Details
Table 58. Siemens Healthineers Business Overview
Table 59. Siemens Healthineers AI In Oncology Product
Table 60. Siemens Healthineers Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 61. Siemens Healthineers Recent Development
Table 62. Intel Company Details
Table 63. Intel Business Overview
Table 64. Intel AI In Oncology Product
Table 65. Intel Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 66. Intel Recent Development
Table 67. GE Healthcare Company Details
Table 68. GE Healthcare Business Overview
Table 69. GE Healthcare AI In Oncology Product
Table 70. GE Healthcare Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 71. GE Healthcare Recent Development
Table 72. NVIDIA Company Details
Table 73. NVIDIA Business Overview
Table 74. NVIDIA AI In Oncology Product
Table 75. NVIDIA Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 76. NVIDIA Recent Development
Table 77. Digital Diagnostics Inc. Company Details
Table 78. Digital Diagnostics Inc. Business Overview
Table 79. Digital Diagnostics Inc. AI In Oncology Product
Table 80. Digital Diagnostics Inc. Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 81. Digital Diagnostics Inc. Recent Development
Table 82. Concert.AI Company Details
Table 83. Concert.AI Business Overview
Table 84. Concert.AI AI In Oncology Product
Table 85. Concert.AI Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 86. Concert.AI Recent Development
Table 87. Median Technologies Company Details
Table 88. Median Technologies Business Overview
Table 89. Median Technologies AI In Oncology Product
Table 90. Median Technologies Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 91. Median Technologies Recent Development
Table 92. Path AI Company Details
Table 93. Path AI Business Overview
Table 94. Path AI AI In Oncology Product
Table 95. Path AI Revenue in AI In Oncology Business (2020-2025) & (US$ Million)
Table 96. Path AI Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. AI In Oncology Picture
Figure 2. Global AI In Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI In Oncology Market Share by Type: 2024 VS 2031
Figure 4. Software Solutions Features
Figure 5. Hardware Features
Figure 6. Services Features
Figure 7. Global AI In Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global AI In Oncology Market Share by Application: 2024 VS 2031
Figure 9. Breast Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Colorectal Cancer Case Studies
Figure 13. Brain Tumor Case Studies
Figure 14. Others Case Studies
Figure 15. AI In Oncology Report Years Considered
Figure 16. Global AI In Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global AI In Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global AI In Oncology Market Share by Region: 2024 VS 2031
Figure 19. Global AI In Oncology Market Share by Players in 2024
Figure 20. Global Top AI In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Oncology as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by AI In Oncology Revenue in 2024
Figure 22. North America AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America AI In Oncology Market Share by Country (2020-2031)
Figure 24. United States AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe AI In Oncology Market Share by Country (2020-2031)
Figure 28. Germany AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific AI In Oncology Market Share by Region (2020-2031)
Figure 36. China AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America AI In Oncology Market Share by Country (2020-2031)
Figure 44. Mexico AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa AI In Oncology Market Share by Country (2020-2031)
Figure 48. Turkey AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE AI In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Azra AI Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 52. IBM Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 53. Siemens Healthineers Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 54. Intel Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 56. NVIDIA Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 57. Digital Diagnostics Inc. Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 58. Concert.AI Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 59. Median Technologies Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 60. Path AI Revenue Growth Rate in AI In Oncology Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Cutting Machines for Diamond Market Research Report 2025
Jul 18, 25
Global RF Shielded Enclosures Market Research Report 2025
Jul 18, 25
Global Padel Court Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232